Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EchoIQ Limited ( (AU:EIQ) ) has shared an announcement.
Echo IQ has expanded its quoted share capital on the ASX by issuing 1.2 million fully paid ordinary shares from the exercise of unlisted options and a further 1.625 million shares from the exercise of vested performance rights. The company confirmed the new shares were issued without a prospectus under the Corporations Act’s cleansing provisions and stated it is compliant with its continuous disclosure and financial reporting obligations, indicating no undisclosed price-sensitive information for investors.
The most recent analyst rating on (AU:EIQ) stock is a Hold with a A$0.66 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.
More about EchoIQ Limited
Echo IQ Limited is an Australian AI and medical technology company that develops proprietary software to enhance decision-making in cardiology. Based in Sydney and listed on the ASX under the ticker EIQ, the company focuses on applying artificial intelligence to improve the accuracy and efficiency of cardiac diagnostics and clinical workflows.
Average Trading Volume: 2,540,932
Technical Sentiment Signal: Buy
Current Market Cap: A$459.9M
See more insights into EIQ stock on TipRanks’ Stock Analysis page.